chr8-120445580-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022045.5(MTBP):c.110A>G(p.Asn37Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Consequence
MTBP
NM_022045.5 missense
NM_022045.5 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: 0.314
Genes affected
MTBP (HGNC:7417): (MDM2 binding protein) This gene encodes a protein that interacts with the oncoprotein mouse double minute 2. The encoded protein regulates progression through the cell cycle and may be involved in tumor formation. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.047742248).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTBP | NM_022045.5 | c.110A>G | p.Asn37Ser | missense_variant | 1/22 | ENST00000305949.6 | NP_071328.2 | |
MTBP | XM_011516962.3 | c.110A>G | p.Asn37Ser | missense_variant | 1/18 | XP_011515264.1 | ||
MTBP | XM_011516963.3 | c.110A>G | p.Asn37Ser | missense_variant | 1/14 | XP_011515265.1 | ||
MTBP | XR_928318.3 | n.162A>G | non_coding_transcript_exon_variant | 1/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTBP | ENST00000305949.6 | c.110A>G | p.Asn37Ser | missense_variant | 1/22 | 1 | NM_022045.5 | ENSP00000303398 | P1 | |
MTBP | ENST00000456899.6 | n.181A>G | non_coding_transcript_exon_variant | 1/3 | 3 | |||||
MTBP | ENST00000522308.1 | n.159A>G | non_coding_transcript_exon_variant | 1/4 | 2 | |||||
MTBP | ENST00000523373.5 | c.110A>G | p.Asn37Ser | missense_variant, NMD_transcript_variant | 1/11 | 5 | ENSP00000430771 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2022 | The c.110A>G (p.N37S) alteration is located in exon 1 (coding exon 1) of the MTBP gene. This alteration results from a A to G substitution at nucleotide position 110, causing the asparagine (N) at amino acid position 37 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Loss of catalytic residue at N37 (P = 0.0132);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.